Demand for Wegovy and other weight-loss drugs has been high for months. Because of this trend, the drug's maker, Novo Nordisk, said May 4 it will decrease its output. 

Pharmacists in New York will now be able to prescribe birth control pills over the counter — eliminating the need for a physicians' sign-off in the process — Gov. Kathy Hochul announced at a May 2 press conference.

The FDA approved GSK's respiratory syncytial virus vaccine intended for adults 60 and older on May 3. It's the first RSV vaccine cleared in the world, the drugmaker said.

Eli Lilly's Alzheimer's drug candidate slowed cognitive decline by 35 percent in a phase 3 study, but the trial revealed some safety risks, including two deaths from brain swelling and nearly 1 in 4 participants experiencing amyloid-related imaging abnormalities. 

After working for more than 20 years on drug shortages, Erin Fox, PharmD, is not burnt out. 

In this episode, we are joined by Steve Zabriski, Pharmacists, MBA, Senior Director, Payer Strategies at Acentrus Specialty, to discuss a novel specialty pharmacy model that promises better care for the sickest patients, an improved patient journey, and may deliver…

As technology and automation continue to advance, pharmacies are in need of pharmacy technicians who specialize in informatics to help implement and troubleshoot innovations as they evolve. The problem? There is no defined, direct career path to becoming one. 

Some gabapentin oral solutions, a medication for seizures, restless legs syndrome and shingles, are currently in shortage, according to the American Society of Health-System Pharmacists. 

A prostate cancer drug candidate from Pfizer and Astellas Pharma reduced the risk of metastasis or death by 58 percent in a phase 3 trial, the two drugmakers said April 29. 

With dozens of experimental gene therapies floating down the research and development pipeline, here are five candidates grabbing headlines: